These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22914190)

  • 1. Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro.
    DeChristopher BA; Loy BA; Marsden MD; Schrier AJ; Zack JA; Wender PA
    Nat Chem; 2012 Sep; 4(9):705-10. PubMed ID: 22914190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo.
    Beans EJ; Fournogerakis D; Gauntlett C; Heumann LV; Kramer R; Marsden MD; Murray D; Chun TW; Zack JA; Wender PA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11698-703. PubMed ID: 23812750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication.
    Marsden MD; Loy BA; Wu X; Ramirez CM; Schrier AJ; Murray D; Shimizu A; Ryckbosch SM; Near KE; Chun TW; Wender PA; Zack JA
    PLoS Pathog; 2017 Sep; 13(9):e1006575. PubMed ID: 28934369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.
    De la Torre-Tarazona HE; Jiménez R; Bueno P; Camarero S; Román L; Fernández-García JL; Beltrán M; Nothias LF; Cachet X; Paolini J; Litaudon M; Alcami J; Bedoya LM
    Biochem Pharmacol; 2020 Jul; 177():113937. PubMed ID: 32224142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
    Wender PA; Hardman CT; Ho S; Jeffreys MS; Maclaren JK; Quiroz RV; Ryckbosch SM; Shimizu AJ; Sloane JL; Stevens MC
    Science; 2017 Oct; 358(6360):218-223. PubMed ID: 29026042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window.
    Sloane JL; Benner NL; Keenan KN; Zang X; Soliman MSA; Wu X; Dimapasoc M; Chun TW; Marsden MD; Zack JA; Wender PA
    Proc Natl Acad Sci U S A; 2020 May; 117(20):10688-10698. PubMed ID: 32371485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters.
    Keck GE; Poudel YB; Welch DS; Kraft MB; Truong AP; Stephens JC; Kedei N; Lewin NE; Blumberg PM
    Org Lett; 2009 Feb; 11(3):593-6. PubMed ID: 19113896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1.
    Kedei N; Lewin NE; Géczy T; Selezneva J; Braun DC; Chen J; Herrmann MA; Heldman MR; Lim L; Mannan P; Garfield SH; Poudel YB; Cummins TJ; Rudra A; Blumberg PM; Keck GE
    ACS Chem Biol; 2013 Apr; 8(4):767-77. PubMed ID: 23369356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-guided design, synthesis, and protein kinase C affinity of a new salicylate-based class of bryostatin analogs.
    Wender PA; Nakagawa Y; Near KE; Staveness D
    Org Lett; 2014 Oct; 16(19):5136-9. PubMed ID: 25238583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
    Darcis G; Kula A; Bouchat S; Fujinaga K; Corazza F; Ait-Ammar A; Delacourt N; Melard A; Kabeya K; Vanhulle C; Van Driessche B; Gatot JS; Cherrier T; Pianowski LF; Gama L; Schwartz C; Vila J; Burny A; Clumeck N; Moutschen M; De Wit S; Peterlin BM; Rouzioux C; Rohr O; Van Lint C
    PLoS Pathog; 2015 Jul; 11(7):e1005063. PubMed ID: 26225566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency.
    Pérez M; de Vinuesa AG; Sanchez-Duffhues G; Marquez N; Bellido ML; Muñoz-Fernandez MA; Moreno S; Castor TP; Calzado MA; Muñoz E
    Curr HIV Res; 2010 Sep; 8(6):418-29. PubMed ID: 20636281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the interactions of phorbol ester and bryostatin complexed with protein kinase C: a comparative molecular dynamics simulation study.
    Thangsunan P; Tateing S; Hannongbua S; Suree N
    J Biomol Struct Dyn; 2016 Jul; 34(7):1561-75. PubMed ID: 26292580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a biorelevant structure of protein kinase C bound modulators: design, synthesis, and evaluation of labeled bryostatin analogues for analysis with rotational echo double resonance NMR spectroscopy.
    Loy BA; Lesser AB; Staveness D; Billingsley KL; Cegelski L; Wender PA
    J Am Chem Soc; 2015 Mar; 137(10):3678-85. PubMed ID: 25710634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of latent HIV using drug-loaded nanoparticles.
    Kovochich M; Marsden MD; Zack JA
    PLoS One; 2011 Apr; 6(4):e18270. PubMed ID: 21483687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved protein kinase C affinity through final step diversification of a simplified salicylate-derived bryostatin analog scaffold.
    Wender PA; Staveness D
    Org Lett; 2014 Oct; 16(19):5140-3. PubMed ID: 25238640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway.
    Staveness D; Abdelnabi R; Near KE; Nakagawa Y; Neyts J; Delang L; Leyssen P; Wender PA
    J Nat Prod; 2016 Apr; 79(4):680-4. PubMed ID: 26900711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostratin as a new therapeutic agent targeting HIV viral reservoirs.
    Hezareh M
    Drug News Perspect; 2005 Oct; 18(8):496-500. PubMed ID: 16391719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis of bryostatin 9.
    Wender PA; Schrier AJ
    J Am Chem Soc; 2011 Jun; 133(24):9228-31. PubMed ID: 21618969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.
    Marsden MD; Wu X; Navab SM; Loy BA; Schrier AJ; DeChristopher BA; Shimizu AJ; Hardman CT; Ho S; Ramirez CM; Wender PA; Zack JA
    Virology; 2018 Jul; 520():83-93. PubMed ID: 29800728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes.
    Ryckbosch SM; Wender PA; Pande VS
    Nat Commun; 2017 Feb; 8(1):6. PubMed ID: 28232750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.